Frank Yiannas, MPH, chief food safety advisor for Boar’s Head and former deputy commissioner for food response at the US Food and Drug Administration, detailed some of the company’s steps to recovery.
Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.
Robert F. Kennedy, Jr., President Trump's nominee to serve as Secretary of Health and Human Services, testifies during a Senate Committee on Health, Education, Labor and Pensions hearing for his ...
Many consumer devices undergo the FDA clearance process, such as LED masks and fitness trackers that have features like ...
11h
Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug ...
The Food and Drug Administration is continuing to investigate several outbreaks of foodborne illnesses and has closed its ...
On December 27, 2024, the US Food and Drug Administration (FDA) published its final rule to update the definition for “healthy” claims on food ...
AB (market cap: $16.28M), a company in the development stage, provided insights into its Q4 2024 performance and future plans during its recent earnings call. The company is advancing its Neola ...
DFA alleges that the agencies violated the Administrative Procedure Act and the Paperwork Reduction Act by removing public ...
More than 80 percent of consumers are worried about food recalls. It’s understandable – recent widespread, highly publicized ...
The anesthetic ketamine is being hailed as a breakthrough therapy for people with post-traumatic stress disorder (PTSD), treatment-resistant depression and other mood disorders.
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback